85 related articles for article (PubMed ID: 27476291)
21. Formulation optimization, in vitro characterization and stability studies of sustain release tablets of Ketoprofen.
Hafeez A; Razvi N; Talib N; Ghayas S; Anjum F; Bushra R
Pak J Pharm Sci; 2019 May; 32(3 (Supplementary)):1245-1251. PubMed ID: 31303597
[TBL] [Abstract][Full Text] [Related]
22. Release kinetics of basic fibroblast growth factor (bFGF) from certain biopolymers in the presence of ketoprofen.
Michalska M; Mirowski M; Bodek A; Bodek KH
Pharmazie; 2010 Nov; 65(11):818-23. PubMed ID: 21155388
[TBL] [Abstract][Full Text] [Related]
23. The delivery of ketoprofen from a system containing ion-exchange fibers.
Yu L; Li S; Yuan Y; Dai Y; Liu H
Int J Pharm; 2006 Aug; 319(1-2):107-13. PubMed ID: 16701973
[TBL] [Abstract][Full Text] [Related]
24. A new approach for preparing a controlled release ketoprofen tablets by using beeswax.
Uner M; Gönüllü U; Yener G; Altinkurt T
Farmaco; 2005 Jan; 60(1):27-31. PubMed ID: 15652365
[TBL] [Abstract][Full Text] [Related]
25. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
[TBL] [Abstract][Full Text] [Related]
27. Plasma deposited stability enhancement coating for amorphous ketoprofen.
Bosselmann S; Owens DE; Kennedy RL; Herpin MJ; Williams RO
Eur J Pharm Biopharm; 2011 May; 78(1):67-74. PubMed ID: 21167280
[TBL] [Abstract][Full Text] [Related]
28. An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen.
Vergote GJ; Vervaet C; Van Driessche I; Hoste S; De Smedt S; Demeester J; Jain RA; Ruddy S; Remon JP
Int J Pharm; 2001 May; 219(1-2):81-7. PubMed ID: 11337168
[TBL] [Abstract][Full Text] [Related]
29. Solid state stability of ketoprofen in the presence of different excipients.
Abd-el-Bary A; Geneidy A; Osman A; Shalaby S; Morshan A
Pharmazie; 1999 Mar; 54(3):202-6. PubMed ID: 10192106
[TBL] [Abstract][Full Text] [Related]
30. Biowaiver monographs for immediate-release solid oral dosage forms: ketoprofen.
Shohin IE; Kulinich JI; Ramenskaya GV; Abrahamsson B; Kopp S; Langguth P; Polli JE; Shah VP; Groot DW; Barends DM; Dressman JB
J Pharm Sci; 2012 Oct; 101(10):3593-603. PubMed ID: 22786667
[TBL] [Abstract][Full Text] [Related]
31. Effects of ultrasound-assisted compaction on Ketoprofen/Eudragit S100 mixtures.
Sancin P; Caputo O; Cavallari C; Passerini N; Rodriguez L; Cini M; Fini A
Eur J Pharm Sci; 1999 Feb; 7(3):207-13. PubMed ID: 9845807
[TBL] [Abstract][Full Text] [Related]
32. The preparation and evaluation of sustained release suppositories containing ketoprofen and Eudragit RL 100 by using factorial design.
Ozgüney I; Ozcan I; Ertan G; Güneri T
Pharm Dev Technol; 2007; 12(1):97-107. PubMed ID: 17484149
[TBL] [Abstract][Full Text] [Related]
33. Film coated tablets (ColoPulse technology) for targeted delivery in the lower intestinal tract: influence of the core composition on release characteristics.
Schellekens RC; Baltink JH; Woesthuis EM; Stellaard F; Kosterink JG; Woerdenbag HJ; Frijlink HW
Pharm Dev Technol; 2012; 17(1):40-7. PubMed ID: 20923321
[TBL] [Abstract][Full Text] [Related]
34. Quantifying drug release from PLGA nanoparticulates.
Corrigan OI; Li X
Eur J Pharm Sci; 2009 Jun; 37(3-4):477-85. PubMed ID: 19379812
[TBL] [Abstract][Full Text] [Related]
35. Optimization of drug release from compressed multi unit particle system (MUPS) using generalized regression neural network (GRNN).
Ivic B; Ibric S; Betz G; Zorica D
Arch Pharm Res; 2010 Jan; 33(1):103-13. PubMed ID: 20191351
[TBL] [Abstract][Full Text] [Related]
36. Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems.
Fadda HM; Merchant HA; Arafat BT; Basit AW
Int J Pharm; 2009 Dec; 382(1-2):56-60. PubMed ID: 19666093
[TBL] [Abstract][Full Text] [Related]
37. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
Patel N; Madan P; Lin S
Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
[TBL] [Abstract][Full Text] [Related]
38. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the utility of an in vitro release test for optimizing semisolid dosage forms.
Proniuk S; Dixon SE; Blanchard J
Pharm Dev Technol; 2001 Aug; 6(3):469-76. PubMed ID: 11485188
[TBL] [Abstract][Full Text] [Related]
40. Comparative evaluation of polymeric and waxy microspheres for combined colon delivery of ascorbic acid and ketoprofen.
Maestrelli F; Zerrouk N; Cirri M; Mura P
Int J Pharm; 2015 May; 485(1-2):365-73. PubMed ID: 25746948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
